The Global Cluster Headache Market Size to grow from USD 355.2 billion in 2021 to USD 626.0 billion by 2030, at a CAGR of 6.5% during the forecast period. The growth of the elderly population, the rising incidence and prevalence of cluster headache syndrome, and the development of new technologies in the healthcare sector are the primary factors driving the market growth.
The COVID-19 pandemic has made an adverse impact on credit portfolios. There has been an unprecedented rise in unemployment and disruption in economic activity, putting a strain on the solvency of customers and companies. Central banks have taken a proactive approach by injecting liquidity into the market by lowering interest rates and asset purchase programs. Managing and monitoring credit, market, liquidity, and operational risk across financial markets were hard enough with ongoing geopolitical tensions, international trade wars, and the occasional hurricanes and earthquakes. The current pandemic situation has forced chief risk officers and their teams to recalibrate old assumptions and models used to manage and monitor risk. COVID-19’s global impact has shown that interconnectedness plays an important role in international cooperation. As a result, many governments started rushing toward identifying, evaluating, and procuring reliable solutions powered by AI.
The chronic segment to account for the largest market size during the forecast period
Based on the type, the Cluster Headache Market is categorized into Episodic and Chronic. The chronic segment accounts for the largest market size during the forecast period. The chronic type of cluster headache affects most patients. The episodic form of the cluster headache may progress over time into the chronic form, or it may be chronic from the beginning, which propels the segment’s growth.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Browse key industry insights spread across 240 pages with 102 market data tables and figures & charts from the report “Global Cluster Headache Market Size, Share, and COVID-19 Impact Analysis By Type (Episodic and Chronic), By Route of Administration (Oral, Intravenous, Topical, and Others), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030.” in detail along with the table of contents
The chronic segment to account for the largest market size during the forecast period
Based on the type, the Cluster Headache Market is categorized into Episodic and Chronic. The chronic segment accounts for the largest market size during the forecast period. The chronic type of cluster headache affects most patients. The episodic form of the cluster headache may progress over time into the chronic form, or it may be chronic from the beginning, which propels the segment’s growth.
Intravenous segment to hold higher CAGR during the forecast period
Based on route of administration type, the Cluster Headache Market is categorized into Oral, Intravenous, Topical, and Others. The intravenous segment to hold higher CAGR during the forecast period. The growth of the intravenous market is anticipated to be driven by factors such as the rising use of the intravenous drugs in treating cluster headaches.
The hospital segment to hold a higher CAGR during the forecast period.
Based on the distribution channel, the Cluster Headache Market is categorized as Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. The hospital segment to hold a higher CAGR during the forecast period. Hospital pharmacies are expected to have a high growth rate owing to the increase in both private and public hospital pharmacies’ funding for the treatment of cluster headaches, as well as an accompanying rise in awareness for the need for early diagnosis. These are the primary reasons driving the expansion of this segment.
Source: Globenewswire
